Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 2a Trial of RO5459072 in Moderate to Severe Psoriasis
2018-002446-36Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of petesicatib in psoriasis, sponsored by Roche. Primary endpoint: PASI75 at week 12. Started Aug 2018; status: completed.
02
Drugs
petesicatib
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2018-002446-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002446-36.